Efficacy classification of modern therapies in multiple sclerosis - Samjoo, Imtiaz A; Worthington, Evelyn; Drudge, Christopher; Zhao, Melody; Cameron, Chris; Häring, Dieter A; Stoneman, Dee; Klotz, Luisa; Adlard, Nicholas (Journal of comparative effectiveness research, 2021)
Keywords: Antibodies; Bans; cladribine; Cladribine - therapeutic use; Classification; Clinical trials; disease-modifying therapy; Drug dosages; Humans; Meta-analysis; Monoclonal antibodies; Multiple sclerosis; Multiple Sclerosis - drug therapy; Multiple Sclerosis, Relapsing-Remitting - drug therapy; network meta-analysis; Neurology; ocrelizumab; ofatumumab; ozanimod; Patients; Recurrence; relapsing multiple sclerosis; treatment guidelines; ozanimod; relapsing multiple sclerosis; ocrelizumab; cladribine; ofatumumab; disease-modifying therapy; treatment guidelines; network meta-analysis